Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.
Xavier Muller,Francesca Marcon,Gonzalo Sapisochin,Max Marquez,Federica Dondero,Michel Rayar,Majella M B Doyle,Lauren Callans,Jun Li,Greg Nowak,Marc-Antoine Allard,Ina Jochmans,Kyle Jacskon,Magali Chahdi Beltrame,Marjolein van Reeven,Samuele Iesari,Alessandro Cucchetti,Hemant Sharma,Roxane D Staiger,Dimitri A Raptis,Henrik Petrowsky,Michelle de Oliveira,Roberto Hernandez-Alejandro,Antonio D Pinna,Jan Lerut,Wojciech G Polak,Eduardo de Santibañes,Martín de Santibañes,Andrew M Cameron,Jacques Pirenne,Daniel Cherqui,René A Adam,Bö-Göran Ericzon,Bjoern Nashan,Kim Olthoff,Avi Shaked,William C Chapman,Karim Boudjema,Olivier Soubrane,Catherine Paugam-Burtz,Paul D Greig,David R Grant,Amanda Carvalheiro,Paolo Muiesan,Philipp Dutkowski,Milo Puhan,Pierre-Alain Clavien
DOI: https://doi.org/10.1097/SLA.0000000000002477
IF: 13.787
2018-01-01
Annals of Surgery
Abstract:Objective: To propose benchmark outcome values in liver transplantation, serving as reference for assessing individual patients or any other patient groups. Background: Best achievable results in liver transplantation, that is, benchmarks, are unknown. Consequently, outcome comparisons within or across centers over time remain speculative. Methods: Out of 7492 liver transplantation performed in 17 international centers from 3 continents, we identified 2024 low risk adult cases with a laboratory model for end-stage liver disease score <= 20 points, a balance of risk score <= 9, and receiving a primary graft by donation after brain death. We chose clinically relevant endpoints covering intra-and postoperative course, with a focus on complications graded by severity including the complication comprehensive index (CCI (R)). Respective benchmarks were derived from the median value in each center, and the 75 percentile was considered the benchmark cutoff. Results: Benchmark cases represented 8% to 49% of cases per center. One-year patient-survival was 91.6% with 3.5% retransplantations. Eighty-two percent of patients developed at least 1 complication during 1-year follow-up. Biliary complications occurred in one-fifth of the patients up to 6 months after surgery. Benchmark cutoffs were <= 4 days for ICU stay, <= 18 days for hospital stay, <= 59% for patients with severe complications (>= Grade III) and <= 42.1 for 1-year CCI (R). Comparisons with the next higher risk group (model for end stage liver disease 21-30) disclosed an increase in morbidity but within benchmark cutoffs for most, but not all indicators, while in patients receiving a second graft from 1 center (n = 50) outcome values were all outside of benchmark values. Conclusions: Despite excellent 1-year survival, morbidity in benchmark cases remains high with half of patients developing severe complications during 1-year follow-up. Benchmark cutoffs targeting morbidity parameters offer a valid tool to assess higher risk groups.